Automated evaluation of autoantibodies on human epithelial-2 cells as an approach to standardize cell-based immunofluorescence tests

Arthritis Research and Therapy

Volumn 12, Issue 2, 2010, Pages

  Egerer, Karl ^a   Roggenbuck, Dirk ^b   Hiemann, Rico ^c   Weyer, Max Georg ^d   Büttner, Thomas ^b   Radau, Boris ^b   Krause, Rosemarie ^a   Lehmann, Barbara ^a   Feist, Eugen ^a   Burmester, Gerd Rüdiger ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^b GA GENERIC ASSAYS GMBH   (Germany)

^c University of Applied Science Lausitz   (Germany)

^d Hygiene und Umweltmedizin ^*  (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOANTIBODY;

ARTICLE; AUTOANALYSIS; CELL ASSAY; CONTROLLED STUDY; CYTOPLASM; DIAGNOSTIC TEST; EPITHELIUM; HUMAN; HUMAN CELL; IMMUNOFLUORESCENCE TEST; INTERMETHOD COMPARISON; LABORATORY TEST; MAJOR CLINICAL STUDY; RHEUMATIC DISEASE; STAINING; BLOOD; CELL LINE; CELL STRAIN HEPG2; ECONOMICS; EVALUATION; FLUORESCENT ANTIBODY TECHNIQUE; IMAGE PROCESSING; IMMUNOLOGY; INFORMATION PROCESSING; METHODOLOGY; OBSERVER VARIATION; REPRODUCIBILITY; SEROLOGY;

AUTOANTIBODIES; AUTOMATIC DATA PROCESSING; CELL LINE; FLUORESCENT ANTIBODY TECHNIQUE, INDIRECT; HEP G2 CELLS; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; OBSERVER VARIATION; REPRODUCIBILITY OF RESULTS; RHEUMATIC DISEASES; SEROLOGIC TESTS;

EID: 77956478503     PISSN: 14786354     EISSN: 14786362     Source Type: Journal    
DOI: 10.1186/ar2949     Document Type: Article

References (41)

1. Damoiseaux JG, Tervaert JW. From ANA to ENA: How to proceed?. Autoimmun Rev 2006, 5:10-17. 10.1016/j.autrev.2005.05.007, 16338206.
2. Fritzler MJ. Challenges to the use of autoantibodies as predictors of disease onset, diagnosis and outcomes. Autoimmun Rev 2008, 7:616-620. 10.1016/j.autrev.2008.06.007, 18603023.
3. Ardoin SP, Pisetsky DS. Developments in the scientific understanding of lupus. Arthritis Res Ther 2008, 10:218. 10.1186/ar2488, 2592776, 18947369.
4. Peene I, Meheus L, Veys EM, De Keyser F. Detection and identification of antinuclear antibodies (ANA) in a large and consecutive cohort of serum samples referred for ANA testing. Ann Rheum Dis 2001, 60:1131-1136. 10.1136/ard.60.12.1131, 1753451, 11709455.
5. Sordet C, Goetz J, Sibilia J. Contribution of autoantibodies to the diagnosis and nosology of inflammatory muscle disease. Joint Bone Spine 2006, 73:646-654. 10.1016/j.jbspin.2006.04.005, 17110150.
6. Worman HJ, Courvalin JC. Antinuclear antibodies specific for primary biliary cirrhosis. Autoimmun Rev 2003, 2:211-217. 10.1016/S1568-9972(03)00013-2, 12848948.
7. Hartung K, Seelig HP. Laboratory diagnostics of systemic autoimmune diseases. Part 1. Collagenoses. Z Rheumatol 2006, 65:709-724. 10.1007/s00393-006-0125-5, 17119898.
8. Tozzoli R, Bizzaro N, Tonutti E, Villalta D, Bassetti D, Manoni F, Piazza A, Pradella M, Rizzotti P, . Italian Society of Laboratory Medicine Study Group on the Diagnosis of Autoimmune Diseases Guidelines for the laboratory use of autoantibody tests in the diagnosis and monitoring of autoimmune rheumatic diseases. Am J Clin Pathol 2002, 117:316-324. 10.1309/Y5VF-C3DM-L8XV-U053, 11863229, Italian Society of Laboratory Medicine Study Group on the Diagnosis of Autoimmune Diseases.
9. Wiik AS, Gordon TP, Kavanaugh AF, Lahita RG, Reeves W, van Venrooij WJ, Wilson MR, Fritzler M, . IUIS/WHO/AF/CDC Committee for the Standardization of Autoantibodies in Rheumatic and Related Diseases Cutting edge diagnostics in rheumatology: the role of patients, clinicians, and laboratory scientists in optimizing the use of autoimmune serology. Arthritis Rheum 2004, 51:291-298. 10.1002/art.20229, 15077275, IUIS/WHO/AF/CDC Committee for the Standardization of Autoantibodies in Rheumatic and Related Diseases.
10. Wiik AS. Anti-nuclear autoantibodies: clinical utility for diagnosis, prognosis, monitoring, and planning of treatment strategy in systemic immunoinflammatory diseases. Scand J Rheumatol 2005, 34:260-268. 10.1080/03009740500202664, 16195158.
11. Craig WY, Ledue TB, Johnson AM, Ritchie RF. The distribution of antinuclear antibody titers in "normal" children and adults. J Rheumatol 1999, 26:914-919.
12. Andrade LE, Chan EK, Peebles CL, Tan EM. Two major autoantigen-antibody systems of the mitotic spindle apparatus. Arthritis Rheum 1996, 39:1643-1653. 10.1002/art.1780391006, 8843854.
13. Herrera-Esparza R, Avalos-Diaz E, Barbosa-Cisneros O. Anti-NuMA antibodies: an uncommon specificity in scleroderma sera. Rev Rhum Engl Ed 1999, 66:315-318.
14. Montecucco C, Caporali R, Cobianchi F, Biamonti G. Identification of autoantibodies to the I protein of the heterogeneous nuclear ribonucleoprotein complex in patients with systemic sclerosis. Arthritis Rheum 1996, 39:1669-1676. 10.1002/art.1780391009, 8843857.
15. Brand F, Martin F, Philipp S, Rößler J, Hansen B, Anderer U. Difference in fluorescence pattern of cytoplasmic and nuclear antigens in cultivated human cells dependent on the applied fixation procedure. Cell Prolif 2005, 38:205.
16. Du L, Fukushima S, Sallmyr A, Manthorpe R, Bredberg A. Exposure of HEp-2 cells to stress conditions influences antinuclear antibody reactivity. Clin Diagn Lab Immunol 2002, 9:287-294. 119933, 11874865.
17. Sack U, Conrad K, Csernok E, Frank I, Hiepe F, Krieger T, Kromminga A, von Landenberg P, Messer G, Witte T, Mierau R, . for the German EASI (European Autoimmunity Standardization Initiative) Autoantibody detection using indirect immunofluorescence on HEp-2 cells. Ann N Y Acad Sci 2009, 1173:166-173. 10.1111/j.1749-6632.2009.04735.x, 19758146, for the German EASI (European Autoimmunity Standardization Initiative).
18. Hiemann R, Büttner T, Krieger T, Roggenbuck D, Sack U, Conrad K. Challenges of automated screening and differentiation of non-organ specific autoantibodies on HEp-2 cells. Autoimmun Rev 2009, 9:17-22. 10.1016/j.autrev.2009.02.033, 19245860.
19. Hiemann R, Hilger N, Michel J, Nitschke J, Böhm A, Anderer U, Weigert M, Sack U. Automatic analysis of immunofluorescence patterns of HEp-2 cells. Ann N Y Acad Sci 2007, 1109:358-371. 10.1196/annals.1398.042, 17785325.
20. Vincent L, Soille P. Watersheds in digital spaces: an efficient algorithm based on immersion simulations. IEEE Trans Pattern Anal Mach Intell 1991, 13:583-598.
21. Cohen J. A coefficient of agreement for nominal scales. Educational and Psychological Measurement 1960, 20:37-46.
22. Tan EM. Autoantibodies to nuclear antigens (ANA): their immunobiology and medicine. Adv Immunol 1982, 33:167-240. full_text, 6182766.
23. Solomon DH, Kavanaugh AJ, Schur PH, . American College of Rheumatology Ad Hoc Committee on Immunologic Testing Guidelines Evidence-based guidelines for the use of immunologic tests: antinuclear antibody testing. Arthritis Rheum 2002, 47:434-444. 10.1002/art.10561, 12209492, American College of Rheumatology Ad Hoc Committee on Immunologic Testing Guidelines.
24. Tan EM, Cohen AS, Fries JF, Masi AT, McShane DJ, Rothfield NF, Schaller JG, Talal N, Winchester RJ. The revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1982, 25:1271-1277. 10.1002/art.1780251101, 7138600.
25. Bayer PM, Bauerfeind S, Bienvenu J, Fabien N, Frei PC, Gilburd B, Heide KG, Hoier-Madsen M, Meroni PL, Monier JC, Monneret G, Panzeri P, Shoenfeld Y, Spertini F, Wiik A. Multicenter evaluation study on a new HEp2 ANA screening enzyme immune assay. J Autoimmun 1999, 13:89-93. 10.1006/jaut.1999.0298, 10441172.
26. Shovman O, Gilburd B, Barzilai O, Shinar E, Larida B, Zandman-Goddard G, Binder SR, Shoenfeld Y. Evaluation of the BioPlex 2200 ANA screen: analysis of 510 healthy subjects: incidence of natural/predictive autoantibodies. Ann N Y Acad Sci 2005, 1050:380-388. 10.1196/annals.1313.120, 16014555.
27. Emlen W, O'Neill L. Clinical significance of antinuclear antibodies: comparison of detection with immunofluorescence and enzyme-linked immunosorbent assays. Arthritis Rheum 1997, 40:1612-1618. 10.1002/art.1780400910, 9324015.
28. Kroshinsky D, Stone JH, Bloch DB, Sepehr A. Case records of the Massachusetts General Hospital. Case 5-2009. A 47-year-old woman with a rash and numbness and pain in the legs. N Engl J Med 2009, 360:711-720. 10.1056/NEJMcpc0807822, 19213685.
29. Mahler M, Ngo JT, Schulte-Pelkum J, Luettich T, Fritzler MJ. Limited reliability of the indirect immunofluorescence technique for the detection of anti-Rib-P antibodies. Arthritis Res Ther 2008, 10:R131. 10.1186/ar2548, 2656233, 19000323.
30. Conrad K, Ittenson A, Reinhold D, Fischer R, Roggenbuck D, Büttner T, Bosselmann HP, Steinbach J, Schössler W. High sensitive detection of double-stranded DNA autoantibodies by a modified Crithidia luciliae immunofluorescence test. Ann N Y Acad Sci 2009, 1173:180-185. 10.1111/j.1749-6632.2009.04801.x, 19758148.
31. Nordal EB, Songstad NT, Berntson L, Moen T, Straume B, Rygg M. Biomarkers of chronic uveitis in juvenile idiopathic arthritis: predictive value of antihistone antibodies and antinuclear antibodies. J Rheumatol 2009, 36:1737-1743. 10.3899/jrheum.081318, 19567622.
32. Rigon A, Soda P, Zennaro D, Iannello G, Afeltra A. Indirect immunofluorescence in autoimmune diseases: assessment of digital images for diagnostic purpose. Cytometry B Clin Cytom 2007, 72:472-477.
33. Soda P. Early experiences in the staining pattern classification of HEp-2 slides. Proceedings of the Twentieth IEEE International Symposium on Computer-Based Medical Systems 2007, 219-224. Washington, DC: IEEE Computer Society.
34. Hu Y, Murphy RF. Automated interpretation of subcellular patterns from immunofluorescence microscopy. J Immunol Methods 2004, 290:93-105. 10.1016/j.jim.2004.04.011, 15261574.
35. Kang I, Siperstein R, Quan T, Breitenstein ML. Utility of age, gender, ANA titer and pattern as predictors of anti-ENA and -dsDNA antibodies. Clin Rheumatol 2004, 23:509-515. 10.1007/s10067-004-0937-0, 15801070.
36. Reimer G, Steen VD, Penning CA, Medsger TA, Tan EM. Correlates between autoantibodies to nucleolar antigens and clinical features in patients with systemic sclerosis (scleroderma). Arthritis Rheum 1988, 31:525-532. 10.1002/art.1780310409, 2451921.
37. Glory E, Murphy RF. Automated subcellular location determination and high throughput microscopy. Dev Cell 2007, 12:7-16. 10.1016/j.devcel.2006.12.007, 17199037.
38. Hiemann R, Hilger N, Sack U, Weigert M. Objective quality evaluation of fluorescence images to optimize automatic image acquisition. Cytometry A 2006, 69:182-184. 10.1002/cyto.a.20224, 16496376.
39. Perner P, Perner H, Müller B. Mining knowledge for HEp-2 cell image classification. Artif Intell Med 2002, 26:161-173. 10.1016/S0933-3657(02)00057-X, 12234722.
40. Soda P, Iannello G. A multi-expert system to classify fluorescent intensity in antinuclear autoantibodies testing. Proceedings of the Nineteenth IEEE International Symposium on Computer-Based Medical Systems 2006, 219-224. Washington, DC: IEEE ComputerSociety.
41. Hollingsworth PN, Dawkins RI, Peter JB. Precise quantitation of antinuclear antibodies on HEp-2 cells without the need for serial dilution. Clin Diagn Lab Immunol 1996, 3:374-377. 170353, 8807199.